GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Small and Large Bowel/The Fiesole Consensus report

The Fiesole Consensus report

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated January 1, 2026

Quick Answer

The Fiesole Consensus Report refers to an international set of guidelines and recommendations on the diagnosis, management, and prevention of diverticular disease. This consensus was developed by a group of 32 experts from 14 countries, employing a structured Delphi process that adheres to the PICO (Population, Intervention, Comparison, Outcome) framework and GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology.


The Fiesole Consensus Report refers to an international set of guidelines and recommendations on the diagnosis, management, and prevention of diverticular disease. This consensus was developed by a group of 32 experts from 14 countries, employing a structured Delphi process that adheres to the PICO (Population, Intervention, Comparison, Outcome) framework and GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology. The report is designed to standardize care and provide evidence-based guidance for clinicians dealing with this increasingly prevalent condition.

### Key Highlights of the Fiesole Consensus Report:

#### 1. **Definitions and Epidemiology**

  • **Diverticulosis**: The presence of colonic diverticula (small pouches in the colon wall) without associated symptoms.
  • **Diverticular disease**: When diverticula are associated with symptoms or complications such as inflammation or infection.
  • Diverticulosis is the most common structural abnormality of the colon in developed countries, with an increasing prevalence worldwide.
  • Approximately 20–25% of individuals with diverticulosis develop symptoms that fall under diverticular disease.

#### 2. **Risk Factors**

  • High dietary fiber intake is protective against diverticular disease.
  • Risk factors include:
  • Smoking
  • Obesity
  • Use of certain medications such as non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, opioids, and immunotherapy agents.

#### 3. **Diagnosis**

  • Imaging is critical for diagnosing suspected acute diverticulitis.
  • **Ultrasound**: May be appropriate when performed by experienced clinicians.
  • **CT Scans**: Preferred for diagnosing complicated cases of diverticulitis.
  • Diverticulosis itself does not require any specific treatment or imaging unless symptoms or complications arise.

#### 4. **Management of Diverticular Disease**

  • **Symptomatic Uncomplicated Diverticular Disease (SUDD)**:
  • Dietary fiber, selected probiotics, mesalazine, and rifaximin may help alleviate symptoms.
  • **Acute Uncomplicated Diverticulitis**:
  • Routine antibiotic use is *not* recommended.
  • **Complicated Diverticulitis**:
  • Imaging is essential to guide management.
  • **Elective Surgery**:
  • Should be individualized based on the patient's quality of life rather than the number of episodes of diverticulitis.

#### 5. **Surgical Management**

  • Surgery is reserved for cases where complications arise or when symptoms significantly impair quality of life.
  • Decisions should prioritize the patient's preferences and overall well-being.

#### 6. **Research Priorities**

  • The report emphasizes the need for further research into:
  • Microbiome characterization in diverticular disease.
  • Genetic risk profiling to better understand individual susceptibility.
  • Long-term outcomes of selective antimicrobial and surgical strategies.

### Conclusion

The Fiesole Consensus Report aims to provide a comprehensive and standardized approach to the diagnosis, treatment, and prevention of diverticular disease. By integrating the latest evidence and expert opinions, the report seeks to optimize patient outcomes across diverse healthcare systems. It also identifies critical gaps in knowledge and highlights areas for future research, ensuring that the management of diverticular disease continues to evolve in alignment with emerging scientific insights.

Related Q&A

Anal High-Grade Squamous Intraepithelial Lesions (HSIL): BJS | March 2026

Introduction: Anal squamous cell carcinoma is an increasingly common but largely preventable cancer. Most cases arise from persistent high-risk human papillomavirus (HPV) infection, progressing through high-grade squamous intraepithelial lesions (HSIL). This comprehensive review summarizes the...

Post-Infection DGBI (PI-DGBI): Gut | July 2026

Introduction: Acute infectious gastroenteritis can trigger persistent gastrointestinal symptoms long after the infection has resolved, leading to post-infection disorders of gut-brain interaction (PI-DGBI). This global Rome Foundation study evaluated the prevalence, risk factors, and clinical...

FMT in IBS: Gastroenterology | July 2026

Introduction: Gut microbiota alterations have been implicated in the pathogenesis of irritable bowel syndrome (IBS), making fecal microbiota transplantation (FMT) a promising therapeutic strategy. However, clinical trials have reported conflicting results. This updated meta-analysis evaluated...

Laparoscopic vs Open Adhesiolysis for Bowel Obstruction: JAMA Surgery | June 2026

Introduction: Laparoscopic adhesiolysis offers several short-term advantages over open surgery for adhesive small bowel obstruction (ASBO). However, its long-term impact on recurrence, quality of life, and incisional hernia remains uncertain. The LASSO trial provides the...

DPP-4 Inhibition Targets the Gut–Brain Axis in Parkinson's Disease: Gut | July 2026

Introduction: Growing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This study investigated whether sitagliptin, a widely used DPP-4 inhibitor for...

Bedside Ultrasound Outperforms Abdominal X-Ray in Neonatal Necrotizing Enterocolitis: Frontiers in Pediatrics | July 2026

Introduction: Necrotizing enterocolitis (NEC) is one of the most serious gastrointestinal emergencies in neonates. Early identification of infants requiring surgical intervention is critical but remains challenging. This study compared bedside abdominal ultrasonography (US) with abdominal...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer